HSP90AA1 and acute myeloid leukemia: Similarly, in AML, whose treatment relies mostly on replicative stress induced by nucleoside analogues, HSP90 inhibition reduces Chk1 and Rad51, two HSP90 client proteins that induce cell cycle arrest and promote homologous reparation repair (HR), respectively.